We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies. Close

Novartis and subsidiaries pay US$346 million in US for corruption

Fraud Intelligence

Novartis and subsidiaries pay US$346 million in US for corruption

Swiss pharmaceuticalsgiant, Novartis AG, plus a former subsidiary Alcon Pte and its current Greekwing, are together to pay out US$345.9 million in fines to American regulatorsbecause of corrupt practices.

The rest of this document is only available to i-law.com online subscribers.

If you are already a subscriber, please enter your details below to log in.

Enter your email address to log in as a user on your corporate account.
Remember me on this computer

Not yet an i-law subscriber?

Devices

Request a trial Find out more